The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 17,801–17,900 of 31,469
Kärkkäinen, H., Laitinen, T. P., Heiskanen, N., Saarelainen, H., Valtonen, P., Lyyra‐Laitinen, T., Vanninen, E. J., & Heinonen, S. T. (2013) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-13-9 · Cited by 15
Association of adipose tissue blood flow with fat depot sizes and adipokines in women
Andersson, J., Karpe, F., Sjöström, L., Riklund, K., Söderberg, S., & Olsson, T. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.152 · Cited by 16
Poortvliet, R. K. E., Lloyd, S. M., Ford, I., Sattar, N. A., de Craen, A. J. M., Wijsman, L. W., Mooijaart, S. P., Westendorp, R. G. J., Jukema, J. W., de Ruijter, W., et al. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu181 · Cited by 16
Mackawy, A. M. H. (2013) · Gene · doi:10.1016/j.gene.2013.07.003 · Cited by 15
Worm, D., Kirk, O., Andersen, O., Vinten, J., Gerstoft, J., Katzenstein, T. L., Nielsen, H. V., & Pedersen, C. D. (2002) · HIV Medicine · doi:10.1046/j.1468-1293.2002.00125.x · Cited by 15
Insulin resistance and enhanced protein glycation in men with prehypertension
Sathiyapriya, V., Nandeesha, H., Bobby, Z., et al. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.264 · Cited by 15
Krug, A. W., Stelzner, L., Rao, A. D., Lichtman, A. H., Williams, G. H., & Adler, G. K. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.011 · Cited by 15
Decreased gastric body mucosa obestatin expression in overweight and obese patients
Gao, X., Kuang, H., Liu, X.-M., et al. (2009) · Peptides · doi:10.1016/j.peptides.2009.11.001 · Cited by 15
Lin, K., Tsay, S., Tsai, S., Kuo, S., & Chou, P. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31803bb22c · Cited by 15
Kanauchi, M., Kanauchi, K., Inoue, T., Kimura, K., & Saito, Y. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.015 · Cited by 15
de Luis, D. A., Sagrado, M. G., Conde, R., et al. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.09.002 · Cited by 15
Preserved insulin response to tolbutamide in hepatocyte nuclear factor‐1α mutation carriers
Sagen, J. V., Pearson, E. R., Johansen, A., Spyer, G., Søvik, O., Pedersen, O. B., Njølstad, P. R., Hattersley, A. T., & Hansen, T. F. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01439.x · Cited by 15
Alves, N. E. G., Enes, B. N., Martino, H. S. D., Alfenas, R. D. C. G., & Ribeiro, S. M. R. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0598-3 · Cited by 15
Risk factors for the development of metabolic syndrome in obese children and adolescents
Folic, N. D., Folić, M., Marković, S., Andjelkovic, M. V., & Јаnkovic, S. (2015) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1504146f · Cited by 14
Insulin secretion and action in different stages of glucose tolerance in Asian Indians
Snehalatha, C., Satyavani, K., Sivasankari, S., Viswanathan, V., & Ramachandran, A. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00084.x · Cited by 16
Body fat distribution and metabolic consequences — Examination opportunities in dogs
Müller, L., Kollár, E., Balogh, L., Pöstényi, Z., Márián, T., Garai, I., Balkay, L., Trencsényi, G., & Thuróczy, J. (2013) · Acta Veterinaria Hungarica · doi:10.1556/avet.2013.057 · Cited by 15
Association between Appendicular Fat Mass and Metabolic Risk Factors
Park, S.-Y., Kwon, K. Y., Kim, J. H., Choi, H. H., Han, K. H., & Han, J. H. (2014) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2014.35.4.182 · Cited by 15
Grieco, C. R., Swain, D. P., Colberg, S. R., Dowling, E., Baskette, K., Zarrabi, L., Gandrakota, R., Kotipalli, U., Sechrist, S. R., & Somma, C. T. (2012) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e31827da2f0 · Cited by 15
Cheng, H. S., Kong, J. M. X. F., Ng, A. X. H., Chan, W. K., Ton, S. H., & Kadir, K. A. (2014) · Natural Products and Bioprospecting · doi:10.1007/s13659-014-0044-0 · Cited by 15
Esteghamati, A., Zandieh, A., Khalilzadeh, O., Morteza, A., Meysamie, A., Nakhjavani, M., & Gouya, M. M. (2010) · Endocrine · doi:10.1007/s12020-010-9374-9 · Cited by 16
Wang, B.-Q., Li, Q., Jiang, Y., Liu, Z., Zhong, L., Luo, R., Cheng, Q., & 青华 (2010) · Inflammation Research · doi:10.1007/s00011-010-0236-y · Cited by 15
Neely, B. A., Carlin, K. P., Arthur, J. M., McFee, W. E., & Janech, M. G. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00132 · Cited by 16
Nallasamy, P., Viswanathan, P., Ravichandran, M. K., et al. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-110 · Cited by 15
Lwow, F., Jędrzejuk, D., Dunajska, K., Milewicz, A., & Szmigiero, L. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.797400 · Cited by 15
Relationship of PGC-1α Gene Polymorphism With Insulin Resistance Syndrome in Korean Children
Ha, C., Cho, J., Han, T., Lee, S., & Kang, H. (2013) · Asia Pacific Journal of Public Health · doi:10.1177/1010539513477685 · Cited by 16
Association between red blood cell distribution width and polycystic ovary syndrome
Yılmaz, Ö., Çalan, M., Kelekçi, S., et al. (2014) · Endocrine Research · doi:10.3109/07435800.2014.987398 · Cited by 15
Vidarsdóttir, S., Roelfsema, F., Frölich, M., & Pijl, H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.11.008 · Cited by 15
Anthropometric Indicators Predict Metabolic Syndrome Diagnosis in Maintenance Hemodialysis Patients
Vogt, B. P., Ponce, D., & Caramori, J. C. T. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615601849 · Cited by 15
Insulin effect on glucose transport in thymocytes and splenocytes from rats with metabolic syndrome
Carbó, R., & Guarner‐Lans, V. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-64 · Cited by 14
Leptin is not associated independently with hypertension in Japanese-Brazilian women
de Almeida-Pititto, B., Gimeno, S. G. A., Freire, R. D., Ribeiro‐Filho, F. F., & Ferreira, S. R. G. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000100012 · Cited by 15
Rajappa, M., Sridhar, M. G., Balachander, J., Sethuraman, K. R., & Rajendiran, K. S. (2014) · ISRN Endocrinology · doi:10.1155/2014/981524 · Cited by 15
Basal metabolic rate in women with PCOS compared to eumenorrheic controls
Churchill, S. J., Wang, E. T., Bhasin, G., Alexander, C. J., Bresee, C. J., Pall, M., Azziz, R., Mathur, R., & Pisarska, M. D. (2015) · Clinical Endocrinology · doi:10.1111/cen.12740 · Cited by 15
Han, S. H., Chin, B. S., Lee, H. S., Jeong, S. J., Choi, H. K., Kim, C. O., Choi, J. Y., Song, Y. G., Lee, H. C., & Kim, J. M. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.021 · Cited by 15
Sharifi, F., Yamini, M., Esmaeilzadeh, A., Mousavinasab, N., & Shajari, Z. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-51 · Cited by 16
You, T., Wang, X., Murphy, K. M., Lyles, M. F., Demons, J. L., Yang, R., Gong, D., & Nicklas, B. J. (2014) · Obesity · doi:10.1002/oby.20743 · Cited by 15
Seo, M. H., Rhee, E., Park, S. E., Park, C., Oh, K. W., Park, S. W., & Lee, W. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.1.73 · Cited by 15
Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women
Gao, H. Y., Meng, J., Xing, H., Nie, S., Xu, M., Zhang, S., Jin, Y., Sun, T., Huang, H., Zhang, H., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu029 · Cited by 15
Çakır, E., Topaloğlu, O., Bozkurt, N. Ç., Karbek, B., Güngüneş, A., Arslan, M. S., Ünsal, İ. Ö., Tutal, E., Uçan, B., & Delibaşı, T. (2014) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1303-80 · Cited by 15
The Relation between Birth Weight and Insulin Resistance in Korean Adolescents
Kim, C. S., Park, J. S., Park, J., et al. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.1.85 · Cited by 15
Berenson, G. S., Patel, D. A., Wang, H., Srinivasan, S. R., & Chen, W. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2007.08.007 · Cited by 15
An, P., Freedman, B. I., Rich, S. S., Mandel, S., Arnett, D. K., Myers, R. H., Chen, Y. I., Hunt, S. C., & Rao, D. C. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0714 · Cited by 15
Helseth, R., Vanky, E., Salvesen, Ø. O., & Carlsen, S. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1107 · Cited by 16
Alemzadeh, R., & Kichler, J. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-35 · Cited by 15
Metabolic syndrome and hepatic resection: improving outcome
Agrawal, S., & Daruwala, C. (2011) · HPB · doi:10.1111/j.1477-2574.2011.00380.x · Cited by 15
van Hees, A. M. J., Saris, W. H. M., Dallinga‐Thie, G. M., Hul, G. B. J., Martínez, J. A., Oppert, J., Štich, V., Astrup, A. V., Arner, P., Sørensen, T. I. A., et al. (2008) · Journal of Nutrition · doi:10.3945/jn.108.094516 · Cited by 15
Kim, I., Williams, R. H., Schutzler, S. E., Lasley, C. J., Bodenner, D., Wolfe, R. R., & Coker, R. H. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-49 · Cited by 15
Poretsky, L., Brillon, D. J., Ferrando, S. J., Chiu, J. A., McElhiney, M. C., Ferenczi, A., Sison, M. C. I. P., Haller, I., & Rabkin, J. G. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.013 · Cited by 15
Shen, D., Ye, H., Wang, Y., Ji, Y. S., Zhan, X., & Zhu, J. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.09.004 · Cited by 15
Nayak, M., Eekhoff, E. M. W., Peinhaupt, M., Heinemann, Á., Desoyé, G., & van Poppel, M. N. M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.11.003 · Cited by 15
Morrison, J. A., Glueck, C. J., Daniels, S. R., Wang, P., & Stroop, D. M. (2011) · Metabolism · doi:10.1016/j.metabol.2011.01.012 · Cited by 15
Kamarck, T. W., Muldoon, M. F., Manuck, S. B., Haskett, R. F., Cheong, J., Flory, J. D., & Vella, E. J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.01.005 · Cited by 14
Ramos, L. F., Shintani, A., Himmelfarb, J., & Ikizler, T. A. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2009.01.028 · Cited by 15
Studies of association between LPIN1 variants and common metabolic phenotypes among 17 538 Danes
Burgdorf, K. S., Sandholt, C. H., Sparsø, T., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0068 · Cited by 15
van Poppel, P. C. M., Breedveld, P., Abbink, E. J., Roelofs, H. M. J., van Heerde, W. L., Smits, P., Lin, W., Tan, A. H., Rüssel, F. G. M., Donders, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128695 · Cited by 15
Metabolic Health Has Greater Impact on Diabetes than Simple Overweight/Obesity in Mexican Americans
Wu, S., Fisher‐Hoch, S. P., Reninger, B., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4094876 · Cited by 15
Sanchez, O. A., Lazo, M., Zeb, I., Tracy, R. P., Bradley, R. D., Duprez, D. A., Bahrami, H., Peralta, C. A., Daniels, L. B., Lima, J. A. C., et al. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.001 · Cited by 16
Sîrbu, A. M., Nicolae, H., Martin, S. C., et al. (2015) · Angiology · doi:10.1177/0003319715586499 · Cited by 15
Obesity, metabolic profile, and inhibition failure: Young women under scrutiny
Catoira, N. P., Tapajóz, F., Allegri, R., Lajfer, J., Cámara, M. J. R., Iturry, M., & Castaño, G. O. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.01.040 · Cited by 16
Sambo, F., Camillo, B. D., Franzin, A., Facchinetti, A., Hakaste, L., Kravić, J., Fico, G., Tuomilehto, J., Groop, L., Gabriel, R., et al. (2015) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7318807 · Cited by 15
Seven, E., Husemoen, L. L. N., Wachtell, K., Ibsen, H., Linneberg, A. R., & Jeppesen, J. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000317 · Cited by 15
Lee, R. K., Hittel, D. S., Nyamandi, V., Kang, L., Soh, J., Sensen, C. W., & Shearer, J. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-159 · Cited by 15
Flores, L. E., Alzugaray, M. E., Cubilla, M. A., Raschia, M. A., Zotto, H. H. D., Román, C. L., Suburo, Á. M., & Gagliardino, J. J. (2013) · Pancreas · doi:10.1097/mpa.0b013e31828fd32d · Cited by 15
Role of insulin resistance in essential hypertension
Tarray, R., Saleem, S. M., Afroze, D., Yousuf, I., Gulnar, A., Laway, B. A., & Verma, S. (2014) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000032 · Cited by 16
Brain natriuretic peptide and insulin resistance in older adults
Kim, F., Biggs, M. L., Kizer, J. R., Brutsaert, E. F., de Filippi, C., Newman, A. B., Kronmal, R. A., Tracy, R. P., Gottdiener, J. S., Djoussé, L., et al. (2016) · Diabetic Medicine · doi:10.1111/dme.13139 · Cited by 15
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., de la Fuente, B., Conde, R., & Primo, D. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318271fb25 · Cited by 15
Insulin Resistance in Young Obese Subjects and Its Relation to Smoking (A Pilot Study)
Juneja, A., Dwivedi, S., Srivastava, D., et al. (2016) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-016-0579-4 · Cited by 15
Ün, B., Dolapçıoğlu, K., Okyay, A. G., Şahin, H. N., & Beyazıt, A. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.06.022 · Cited by 15
Stawerska, R., Czkwianianc, E., Smyczyńska, J., et al. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001387 · Cited by 15
Silva, J. S., Chaves, G. V., Stenzel, A., Pereira, S., Saboya, C. J., & Ramalho, A. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.09.002 · Cited by 15
Carpéné, C., Les, F., Hasnaoui, M., Biron, S., Marceau, P., Richard, D., Galitzky, J., Joanisse, D. R., & Mauriège, P. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0526-0 · Cited by 15
Yarmolinsky, J., Mueller, N. T., Duncan, B. B., Chor, D., Benseñor, I. M., Griep, R. H., Appel, L. J., Barreto, S. M., & Schmidt, M. I. (2016) · Scientific Reports · doi:10.1038/srep37032 · Cited by 16
Zhang, L., Zhang, M., Wang, J. J., Wang, C., Ren, Y., Wang, B. Y., Zhang, H., Yang, X. Y., Zhao, Y., Han, C. Y., et al. (2016) · PubMed · doi:10.3967/bes2016.108 · Cited by 15
Atherogenic Dyslipidemia Remission 1 Year After Bariatric Surgery
Climent, E., Benaiges, D., Pedro‐Botet, J., Roux, J. A. F., Ramón, J. M., Villatoro, M., Fontané, L., Chillarón, J. J., & Goday, A. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2504-6 · Cited by 15
Madeshiya, A. K., Singh, S., DWIVEDI, S., et al. (2017) · Journal of Genetics · doi:10.1007/s12041-016-0738-7 · Cited by 15
Cognitive impairment is correlated with insulin resistance degree: the “PA-NICO-study”
Fava, A., Colica, C., Plastino, M., Messina, D., Cristiano, D., Opipari, C., Vaccaro, A., Gorgone, G., Bosco, F., Fratto, A., et al. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-9977-4 · Cited by 17
Jankowska, M. M., Natarajan, L., Godbole, S. V., Meseck, K., Sears, D. D., Patterson, R. E., & Kerr, J. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0927 · Cited by 15
Maraninchi, M., Padilla, N., Béliard, S., Berthet, B., Nogueira, J. P., Dupont-Roussel, J., Mancini, J., Corroller, A. B., Dubois, N., Grangeot, R., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.02.012 · Cited by 16
Foghsgaard, S., Vedtofte, L., Andreasen, C. H., Andersen, E. S., Bahne, E., Bagger, J. I., Svare, J., Holst, J. J., Clausen, T. D., Mathiesen, E. R., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4265-8 · Cited by 19
Ergogenic properties of metformin in simulated high altitude
Scalzo, R. L., Paris, H. L. R., Binns, S. E., Davis, J., Beals, J. W., Melby, C. L., Luckasen, G. J., Hickey, M. S., Miller, B. F., Hamilton, K. L., et al. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12761 · Cited by 15
Serum RBP4 and CKD: Association with insulin resistance and lipids
Domingos, M. A. M., Queiroz, M. S., Lotufo, P. A., Benseñor, I. M., & Titan, S. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.04.013 · Cited by 15
de Medeiros, S. F., Yamamoto, M. M. W., de Medeiros, M. A. S., et al. (2017) · PubMed · Cited by 15
Serra, M. C., Blumenthal, J. B., Addison, O. R., Miller, A. J., Goldberg, A. P., & Ryan, A. S. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000475766 · Cited by 15
INSULIN RESISTANCE AND POLYCYSTIC OVARY SYNDROME IN A CHINESE POPULATION
Chen, C., Jing, G., Zhou, L., Juan, S., Bin, C., & Jie, H. (2017) · Endocrine Practice · doi:10.4158/ep171849.or · Cited by 15
Lyubarova, R., Robinson, J. G., Miller, M. J., Simmons, D. L., Xu, P., Abramson, B. L., Elam, M. B., Brown, T. M., McBride, R., Fleg, J. L., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.06.017 · Cited by 15
Gardner, A. W., Montgomery, P. S., Zhao, Y. D., Ungvari, Z. I., Csiszár, A., & Sonntag, W. E. (2017) · Angiology · doi:10.1177/0003319717726934 · Cited by 15
Increased insulin resistance in men with unexplained infertility
Mansour, R., El-Faissal, Y., Kamel, A., Kamal, O., Aboulserour, G., Aboulghar, M. A., & Fahmy, I. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.08.020 · Cited by 17
Shiba, T., Takahashi, M., Matsumoto, T., & Hori, Y. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3141678 · Cited by 15
Glucose homeostasis in GHD children during long-term replacement therapy: a case−control study
Capalbo, D., Esposito, A. A., Improda, N., Wasniewska, M. G., Mase, R. D., Luca, F. D., Bruzzese, D., & Salerno, M. (2017) · Endocrine · doi:10.1007/s12020-017-1408-0 · Cited by 15
Aryan, Z., Afarideh, M., Ghajar, A., Esteghamati, S., Esteghamati, A., & Nakhjavani, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.037 · Cited by 16
Ko, K., Wu, Y., Liu, C., Cheng, M., Yen, R., & Yang, W. (2017) · Oncotarget · doi:10.18632/oncotarget.21202 · Cited by 15
Papandreou, D., Karavolias, C., Arvaniti, F., et al. (2017) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2017.182 · Cited by 15
Zhou, J., Wang, D., Luo, X., Xu, J. Y., Li, M., Laudon, M., Zhang, R., & Jia, Z. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.243998 · Cited by 15
Hwang, D.-N., Cho, M.-R., Choi, M., Lee, S., & Park, Y. (2017) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2017.38.6.372 · Cited by 15
Canivell, S., Mohaupt, M. G., Ackermann, D., Pruijm, M. T., Guessous, I., Ehret, G., Escher, G., Péchère-Bertschi, A., Vogt, B., Devuyst, O., et al. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0807-7 · Cited by 15
Camillo, B. D., Hakaste, L., Sambo, F., Gabriel, R., Kravić, J., Isomaa, B., Tuomilehto, J. O., Alonso, M., Longato, E., Facchinetti, A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0921 · Cited by 16
Torres‐Castillo, N., Campos-Perez, W. Y., González‐Becerra, K., Hernández‐Cañaveral, I., Vizmanos-Lamotte, B., Muñóz-Valle, J. F., & Martínez‐López, E. (2018) · Nutrients · doi:10.3390/nu10040447 · Cited by 15
Polak, J., Punjabi, N. M., & Shimoda, L. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00280 · Cited by 14
Graae, A.-S., Hollensted, M., Kloppenborg, J. T., Mahendran, Y., Schnurr, T. M., Appel, E. V. R., Rask, J., Nielsen, T. R. H., Johansen, M. Ø., Linneberg, A. R., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4640-0 · Cited by 15
Ruan, J., Lin, J.-K., Kuo, Y.-Y., Chen, Y., & Chen, P. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.05.005 · Cited by 15
Garay‐Sevilla, M. E., Torres‐Graciano, S., Villegas‐Rodríguez, M. E., Cisneros, A. E. R., Wróbel, K., & Uribarri, J. (2018) · Acta Paediatrica · doi:10.1111/apa.14426 · Cited by 15
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
